| PLX Stock | | | USD 1.24 0.08 6.06% |
Protalix Biotherapeutics financial indicator trend analysis is much more than just breaking down Protalix Biotherapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protalix Biotherapeutics is a good investment. Please check the relationship between Protalix Biotherapeutics Total Assets and its Cash accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Protalix Stock please use our
How to Invest in Protalix Biotherapeutics guide.
Total Assets vs Cash
Total Assets vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Protalix Biotherapeutics Total Assets account and
Cash. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Protalix Biotherapeutics' Total Assets and Cash is 0.85. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Cash in the same time period over historical financial statements of Protalix Biotherapeutics, assuming nothing else is changed. The correlation between historical values of Protalix Biotherapeutics' Total Assets and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Protalix Biotherapeutics are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Assets i.e., Protalix Biotherapeutics' Total Assets and Cash go up and down completely randomly.
Correlation Coefficient | 0.85 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Total Assets
Total assets refers to the total amount of Protalix Biotherapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Protalix Biotherapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Cash
Cash refers to the most liquid asset of Protalix Biotherapeutics, which is listed under current asset account on Protalix Biotherapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Protalix Biotherapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Protalix Biotherapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Protalix Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protalix Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Protalix Stock please use our
How to Invest in Protalix Biotherapeutics guide.At this time, Protalix Biotherapeutics'
Selling General Administrative is fairly stable compared to the past year.
Tax Provision is likely to rise to about 287.5
K in 2024, despite the fact that
Discontinued Operations is likely to grow to (206.5
K).
Protalix Biotherapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Protalix Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Protalix Biotherapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to
measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to
predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.